http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2402687-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_886a6eed19ee9de30a2640e774181b7f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-733 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-733 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
| filingDate | 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_603cb348fea6b73b717bfa9baa4c04a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d3f391828c0b4916a36e1a4e26e273 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf235c919dbbe051595e843b79439b3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67930d8e76cfc5a6fc1eee31c28948e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_936ab3830151025fa3b85b7332412c05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48c63a302fc7f5b379c4e2969faec10c |
| publicationDate | 2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2402687-T3 |
| titleOfInvention | Use of sphingomyelin and non-digestible carbohydrates to improve intestinal microbiota |
| abstract | Use of a nutritional composition that includes: A. Use of a nutritional composition that includes: A. Use of a nutritional composition that includes: A. sphingophospholipid, preferably sphingomyelin sphingophospholipid, preferably sphingomyelin sphingophospholipid, preferably sphingomyelin, and / or at least one product of degradation of sphincter, and / or at least one degradation product of sphincter, and / or at least one degradation product of sphingophospholipid selected from the group consisting of gophospholipid selected from the group consisting of gophospholipid selected from the group consisting of: ceramide, lysosphingophospholipid, phosphate sphincter : ceramide, lysosphingophospholipid, phosphate sphincter: ceramide, lysosphingophospholipid, sphingoid phosphate and free sphingoid base, and B. at least fructngoid and free sphingoid base, and B. at least fructngoid and free sphingoid base, and B. at least fructo-oligosaccharides and galacto-oligosaccharides , for lao-oligosaccharides and galacto-oligo saccharides, for lao-oligosaccharides and galacto-oligosaccharides, for the manufacture of a composition to normalize the manufacture of a composition to normalize the manufacture of a composition to normalize the intestinal microbiota in a human subject to the intestinal microbiota in a human subject to l intestinal microbiota in a human subject to the microbiota found in thin subjects greeted microbiota found in thin subjects greeted microbiota found in healthy thin subjects and / or breastfed babies, where the compositional and / or breastfed babies, where the compositional and / or breastfed babies, where the composition of the microbiotaintestinal is normalized with respect to the microbiotaintestinal is normalized with respect to the microbiotaintestinal is normalized with respect to at least one element selected from the group cto to at least one element selected from the group cto to at least one element selected from the group consisting of: an increase in the prebiotic index, which consists of: an increase in the prebiotic index, which consists of: an increase in the prebiotic index, an increase in the Bifidobacteria / bacteriin ratio, an increase in the Bifidobacteria / bacteriin ratio, an increase in the Bifidobacteria / total bacteria ratio, and a decrease in the proportion Total signatures and a decrease in the proportion Total signatures and a decrease in the proportion Signature / Bacteroidetes. cutes / bacteroidetes. cutes / bacteroidetes. |
| priorityDate | 2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.